Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.46 USD | -3.97% | -31.34% | +75.91% |
Apr. 22 | GlucoTrack, Inc. announced that it has received $0.5 million in funding | CI |
Apr. 16 | Glucotrack Expanding Glucose Monitoring Technology to Epidural Space | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.46M |
---|---|---|---|---|---|
Net income 2022 | -4M | Net income 2023 | -7M | EV / Sales 2022 | - |
Net cash position 2022 | 2.12M | Net cash position 2023 | 4.3M | EV / Sales 2023 | - |
P/E ratio 2022 |
-4.92
x | P/E ratio 2023 |
-0.68
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.25% |
1 day | -3.97% | ||
1 week | -31.34% | ||
Current month | +38.93% | ||
1 month | +37.77% | ||
3 months | +109.09% | ||
6 months | +134.69% | ||
Current year | +75.91% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Goode
CEO | Chief Executive Officer | 56 | 20-12-16 |
James Cardwell
DFI | Director of Finance/CFO | 64 | 23-10-10 |
David Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Drew Sycoff
BRD | Director/Board Member | 57 | 19-07-07 |
Luis J. Malavé
CHM | Chairman | 61 | Feb. 12 |
Director/Board Member | 95 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.46 | -3.97% | 238,295 |
24-04-24 | 0.479 | -36.97% | 1,704,258 |
24-04-23 | 0.76 | -15.65% | 275,696 |
24-04-22 | 0.901 | +9.88% | 390,822 |
24-04-19 | 0.82 | +22.39% | 194,265 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+75.91% | 12.31M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.75% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- GCTK Stock